These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7882575

  • 1. Sodium loads enhance the natriuretic responses to atrial natriuretic peptide and neutral endopeptidase inhibitors in conscious cynomolgus monkeys.
    Seymour AA, Asaad MM, Abboa-Offei B, Smith PL, Rogers WL.
    Clin Exp Pharmacol Physiol; 1994 Nov; 21(11):845-56. PubMed ID: 7882575
    [Abstract] [Full Text] [Related]

  • 2. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
    Seymour AA, Asaad MM, Abboa-Offei BE, Smith PL, Rogers WL, Dorso CR.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
    Seymour AA, Asaad MM, Abboa-Offei BE, Rovnyak PL, Fennell S, Rogers WL.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
    Seymour AA, Abboa-Offei BE, Smith PL, Mathers PD, Asaad MM, Rogers WL.
    Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):63-9. PubMed ID: 7768036
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.
    Seymour AA, Abboa-Offei B, Asaad MM, Rogers WL.
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819
    [Abstract] [Full Text] [Related]

  • 6. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR, Settle SL, Kirk JE, Taylor SA, Moore KP, Unwin RJ.
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [Abstract] [Full Text] [Related]

  • 7. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats.
    Seymour AA, Norman JA, Asaad MM, Fennell SA, Swerdel JN, Little DK, Dorso CR.
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660
    [Abstract] [Full Text] [Related]

  • 8. Renal and depressor activities of inhibitors of neutral endopeptidase and angiotensin converting enzyme in monkeys infused with angiotensin II.
    Seymour AA, Asaad MM, Abboa-Offei BE, Smith PL, Mathers PD, Rogers WL, Dorso CR.
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):651-8. PubMed ID: 8945678
    [Abstract] [Full Text] [Related]

  • 9. Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors.
    Seymour AA, Mathers PD, Abboa-Offei BE, Asaad MM, Weber H.
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):397-401. PubMed ID: 8877586
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
    Seymour AA, Norman JA, Asaad MM, Fennell SA, Little DK, Kratunis VJ, Rogers WL.
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235
    [Abstract] [Full Text] [Related]

  • 11. Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs. A possible role for kinins and luminal actions of the peptide.
    Legault L, Cernacek P, Levy M, Maher E, Farber D.
    J Clin Invest; 1992 Oct; 90(4):1425-35. PubMed ID: 1328299
    [Abstract] [Full Text] [Related]

  • 12. Amplification by atrial natriuretic peptide of the haemodynamic and renal responses to an acute volumic stress in the rat.
    Caron N, Simon F, Plennevaux F, Michel A, Kramp R.
    Clin Exp Pharmacol Physiol; 1999 Apr; 26(4):315-22. PubMed ID: 10225142
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072.
    Seymour AA, Fennell SA, Swerdel JN.
    Hypertension; 1989 Jul; 14(1):87-97. PubMed ID: 2544529
    [Abstract] [Full Text] [Related]

  • 14. Potentiation of the depressor responses to atrial natriuretic peptides in conscious SHR by an inhibitor of neutral endopeptidase.
    Seymour AA, Swerdel JN, Fennell SA, Druckman SP, Neubeck R, Delaney NG.
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):194-204. PubMed ID: 2476591
    [Abstract] [Full Text] [Related]

  • 15. Role of atrial natriuretic peptide in sodium balance in conscious spontaneously hypertensive rats.
    Seymour AA, Swerdel JN, Fennell SA, Kratunis VJ, Asaad MM.
    Am J Physiol; 1990 Apr; 258(4 Pt 2):F916-26. PubMed ID: 2139545
    [Abstract] [Full Text] [Related]

  • 16. Renal denervation potentiates the natriuretic and diuretic effects of atrial natriuretic peptide in anaesthetized rabbits.
    Christy IJ, Denton KM, Anderson WP.
    Clin Exp Pharmacol Physiol; 1994 Jan; 21(1):41-8. PubMed ID: 8156651
    [Abstract] [Full Text] [Related]

  • 17. Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats.
    Gardiner SM, Kemp PA, Bennett T.
    Br J Pharmacol; 1992 May; 106(1):180-6. PubMed ID: 1387023
    [Abstract] [Full Text] [Related]

  • 18. Four-hour atrial natriuretic peptide infusion in conscious rats: effects on urinary volume, sodium, and cyclic GMP.
    Campbell HT, Lightfoot BO, Sklar AH.
    Proc Soc Exp Biol Med; 1988 Dec; 189(3):317-24. PubMed ID: 2849771
    [Abstract] [Full Text] [Related]

  • 19. Atrial natriuretic peptide in chronically hypertensive dogs.
    Seymour AA, Asaad MM, Sheldon JH, Smith PL, Rogers WL.
    Hypertension; 1995 Oct; 26(4):634-41. PubMed ID: 7558224
    [Abstract] [Full Text] [Related]

  • 20. Atrial natriuretic peptide is involved in renal actions of moxonidine.
    Mukaddam-Daher S, Gutkowska J.
    Hypertension; 2000 Jun; 35(6):1215-20. PubMed ID: 10856266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.